Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(20%)

Results Posted

150%(3 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_2

40%

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

2(40.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Recruiting1

Terminated1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (40.0%)

N/A3 (60.0%)

Trials by Status

recruiting120%

completed240%

terminated120%

not_yet_recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy

NCT03696576

completedphase_2

Expiratory Muscle Training for Persons With Neurodegenerative Disease

NCT00856518

Clinical Trials (5)

Showing 5 of 5 trials

NCT07371351Not Applicable

"Effects of EMST and Triflo on Voice Parameters and Vocal Fatigue"

Not Yet Recruiting

NCT03916809Not Applicable

EMST in Patients Undergoing CRT for HNCA

Recruiting

NCT02927691Phase 2

Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial

Completed

NCT03696576Not Applicable

Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy

Terminated

NCT00856518Phase 2

Expiratory Muscle Training for Persons With Neurodegenerative Disease

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5